منابع مشابه
five-year evaluation of chronic diseases in hamadan, iran: 2005-2009
background: now the increasing growth of chronic diseases is the major health challenge worldwide. this survey was conducted to assess noncommunicable diseases related risk factors. methods: a population-based cross sectional study was conducted in 2005 and repeated annually by 2009 in hamadan province, the west of iran using two-stage cluster sampling method. a total sample of 6500 subjects 15...
متن کاملFive-year Evaluation of Chronic Diseases in Hamadan, Iran: 2005–2009
BACKGROUND Now the increasing growth of chronic diseases is the major health challenge worldwide. This survey was conducted to assess noncommunicable diseases related risk factors. METHODS A population-based cross sectional study was conducted in 2005 and repeated annually by 2009 in Hamadan province, the west of Iran using two-stage cluster sampling method. A total sample of 6500 subjects 15...
متن کاملTelephony in the Year 2005
The growth of packet-based voice services is leading to integration of voice and other services over packet switched data networks. This paper explores a possible path that the telephone service industry may follow as this integration is accelerated by technological advances that improve the capabilities of packet-based services while reducing their costs. q 1999 Elsevier Science B.V. All right...
متن کاملNigella sativa: Valuable perspective in the management of chronic diseases
Objective(s): Over the past 20 years, increasing interest in the use of medicinal plants as alternative or adjuvant treatments of several chronic diseases was observed. Accordingly, Nigella sativa or black cumin, a medicinal plant rich in bioactive compounds, has been used worldwide for food purposes or in traditional medicines. This paper aims to reveal N. sativa pote...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 1995
ISSN: 0003-4967
DOI: 10.1136/ard.54.11.866